Sea change in treatment of late-stage breast cancer
New inhibitor drug used for patients with the most common type of stage four breast cancer
Sign up now: Get ST's newsletters delivered to your inbox
Ms Christina Ng, 59, a patient with stage four breast cancer, was one of those who enrolled for the phase III Monaleesa-2 study. More than four years later, Ms Ng no longer experiences pain and a scan in November last year showed the mass in her underarm had shrunk by 90 per cent.
ST PHOTO: SYAZA NISRINA
Ms Christina Ng, 59, first felt pain in her upper left arm about six years ago. It started as a dull ache that wouldn't go away.
"I thought it was caused by stress so I decided to quit my job as an accountant. But the pain got more intense. It would creep into my fingertips," the breast cancer survivor told The Straits Times in an interview last week.
